Stay updated with breaking news from Sandra Casimiro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A promising target has been identified in cancer cells that could be used in combination with standard care to prevent acquired treatment resistance in metastatic breast cancer.
Brest cancer is the most common cancer in women. Among breast tumors that spread to other organs (develop metastasis), 70% belong to a variant, called luminal, whose cells are sensitive to the female sex hormones estrogen and progesterone. In fact, the tumor forms when these hormones order the cells to divide.